FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira 0.9% Sodium Chloride Injection Recall

0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest,…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Apr 10, 2013
Recall ID
D-243-2013
Check your lot numberHow we source this data

Summary

Hospira recalled 0.9% Sodium Chloride Injection starting Feb 18, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-243-2013 on Apr 10, 2013. Reason: Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.

Product description

0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36 Hospira, Inc., Lake Forest, IL 60045

Lot numbers, UPCs & expiration codes

Lot #: 22-028-JT Exp 04/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-243-2013
Classification
Class II
Status
Terminated
Recall initiated
Feb 18, 2013
FDA report date
Apr 10, 2013
Quantity
624,240 units
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-243-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
64481
Address
275 N Field Dr
Code information
Lot #: 22-028-JT Exp 04/14
Postal code
60045-2579
Report date
Apr 10, 2013
Product type
Drugs
Recall number
D-243-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
624,240 units
Termination date
Apr 6, 2015
Reason for recall
Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36 Hospira, Inc., Lake Forest, IL 60045
Distribution pattern
Nationwide
Recall initiation date
Feb 18, 2013
Initial firm notification
Letter
Center classification date
Apr 4, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-243-2013, published Apr 10, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls